MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
shares in...
$4,347K
Proceeds from warrants
issuance (note 7)
$1,501K
Proceeds from short-term
loans (note 11)
$582K
Debt-for-equity swap
-$450K
Total net cash
provided by financing...
$6,880K
Decrease in cash and cash
equivalents
-$95K
Canceled cashflow
$6,880K
Stock-based compensation
related to options...
$1,520K
Increase (decrease) in
trade payables
$987K
Increase (decrease) in
employees related...
$716K
Depreciation
$199K
Change in operating
lease liability, net
$87K
Increase in accrued
expense
$85K
Total net cash used in
operating activities
-$6,975K
Canceled cashflow
$3,594K
Net loss
-$10,307K
Gain on change in fair
value of warrants...
-$179K
Decrease (increase) in
prepaid expenses and...
$83K
Back
Back
Cash Flow
source: myfinsight.com
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)